Delta Phenomics is a privately held company providing contract research, consultancy and training services for pharmaceutical and nutrition companies, governmental agencies and academic institutions. Our expertise in rat and mouse behavior, neuroscience and pharmacology is combined with a unique automated behavioral testing and data analysis platform. This allows us to screen mutant lines and compound libraries at high throughput and deliver extensive behavioral profiles in a cost-effective manner.

The company was founded by Prof. Dr. Berry Spruijt and Dr. Lucas Noldus, and commenced operations in January 2008. The founders have a long track record in methodological and technical innovation, and have collaborated since the early nineties on the development of novel scientific software and instrumentation for the automated observation of animal behavior, and its application in behavioral neuroscience. Their teams have gained a vast amount of experience in laboratory automation, computer vision, data acquisition and analysis, both as developers, testers and users. In the early 90s they co-developed EthoVision, the first software-based video tracking system for automation of behavioral tests.

Delta Phenomics engages in collaborative partnerships with pharmaceutical, nutrition and biotechnology companies as well as with university and research institute scientists. Projects can include development and validation of novel behavioral test paradigms, phenotyping of mouse or rat mutants, screening for identification of new lead compounds for diseases, and related drug and target discovery work. Last but not least as we may apply a wide spectrum approach for the observation and analysis of behavior we are keen in detecting side effects of treatments. If you have a specific project idea, please contact us.